Mankind Pharma Acquires BSV from Advent for ₹13.6K Crore
Mankind Pharma is acquiring biotech firm BSV Group from Advent International for approximately ₹13,630 crore. This acquisition will strengthen Mankind’s position in India’s women's health and fertility markets, raising its market share to 13%. BSV, known for its innovative R&D and manufacturing capabilities, reported ₹1,723 crore in revenue for FY24. The deal involves internal funding and a mix of debt and equity.
- #general surgery
- #pharmacology
- #general medicine
- #psych
- #rheumatology
- #pathology
- #radiology
- #anaesthesia
- #psychiatry
- #fmt
- #emergency medicine
- #academics
- #nursing
- #pharmacy
- #trichology
- #andrology
- #orthopaedics
- #critical care
- #dermatology
- #dentistry
- #oncology
- #business
- #gastroenterology
- #nephrology
- #diagnostics
- #urology
- #ophthalmology
- #gynaecology - ivf
- #pediatrics
- #neurology
- #ent
- #pulmonology
- #family health
- #cardiology
- #endo-diabetology